Fuzheng Huayu tablet

DRUG2 trials

Sponsors

ShuGuang Hospital

Conditions

Novel Coronavirus PneumoniaPulmonary Fibrosis Due to COVID-19

Phase 2

Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

CompletedNCT04279197

ShuGuang HospitalPulmonary Fibrosis Due to COVID-19

Start: 2020-04-23End: 2021-03-24Updated: 2022-01-03

Phase 4

Effects of Fuzheng Huayu Tablets on COVID-19

CompletedNCT04645407

ShuGuang HospitalNovel Coronavirus Pneumonia

Start: 2020-02-01End: 2020-04-15Updated: 2020-11-27

Related Papers

Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial

Frontiers in Pharmacology2025-03-112 citations